Senate Democrats have demanded an ethics probe into Tom Price, President-elect Donald Trump’s pick for Secretary of the Department of Health and Human Services, following a report that he traded in health care company stocks while supporting legislation in Congress that could affect those shares, according to an article posted by the Reuters news service.
Senate Democratic leader Chuck Schumer and others made the demand as Republicans forged ahead with their plan to repeal the Patient Protection and Affordable Care Act (PPACA). The Democrats called on the Office of Congressional Ethics to investigate Price’s stock trades.
“Every American should be shocked by this,” Schumer told reporters.
Phil Blando, a Trump transition spokesman, called Schumer’s demand a “stunt” to deflect attention from the PPACA’s “dismal record.”
Blando said the ethics questions Schumer raised about Price should be directed to three sitting Democratic senators, Delaware’s Tom Carper, Virginia’s Mark Warner, and Rhode Island’s Sheldon Whitehouse, “who own and have traded hundreds of thousands of dollars in pharmaceutical and health insurance company stocks.”
“Hypocrisy is apparently alive and well this morning in Washington,” Blando said.
Republicans will control the White House and Congress once Donald Trump takes office on January 20. In a series of Twitter posts, Trump has blasted the Democrats over the PPACA, taunting Schumer as “head clown.”
Source: Reuters; January 5, 2017.